U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07589075) titled 'Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation' on Aug. 08, 2025.
Brief Summary: The aim of the study is to assess the efficacy of adjuvant therapy dapagliflozin, metformin as monotherapy and combination of both in comparison to control group in induction of ovulation with letrozole in women PCOS, focusing specifically on rates of ovulation and pregnancy.
Study Start Date: Oct. 20, 2023
Study Type: INTERVENTIONAL
Condition:
Induction of Ovulation
Intervention:
DRUG: Metformin 1000 mg
will take Metformin 1000 mg once daily with a main meal and started one month before ini...